Dark

CYTR
CYTRX CORP
stock OTC

Inactive

Oct 5, 2022

0.0920USD0.000%(0.0000)4,048

Pre-market

0.00USD-100.000%(-0.09)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

CEO

Steven Kriegsman

Headquarters

Los Angeles, California, USA

Industry

Biotechnology

Last Split

Nov 1, 20171for6reverse

AMGN CELG SGEN CLDX GSK NVS XLV

Profile

CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS).

.dark-mode .n8rV6C{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .n8rV6C{ color: #333333; background-color: white; border: 2px solid #333333; }CYTRCYTRX CORPstock OTC

CYTR
CYTRX CORP
stock OTC